Orchard Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-121,020
| Closed | -$6.5M | – | 54 |
|
|
2022
Q3 | $6.5M | Hold |
121,020
| – | – | 2.43% | 19 |
|
|
2022
Q2 | $6.94M | Buy |
121,020
+3,046
| +3% | +$175K | 2.17% | 24 |
|
|
2022
Q1 | $8.28M | Buy |
117,974
+8,015
| +7% | +$562K | 2.35% | 19 |
|
|
2021
Q4 | $10.6M | Buy |
109,959
+2,084
| +2% | +$201K | 3.11% | 15 |
|
|
2021
Q3 | $9.38M | Hold |
107,875
| – | – | 2.82% | 16 |
|
|
2021
Q2 | $8.83M | Buy |
107,875
+3,391
| +3% | +$278K | 2.55% | 18 |
|
|
2021
Q1 | $9.94M | Buy |
104,484
+10,034
| +11% | +$954K | 3.13% | 14 |
|
|
2020
Q4 | $5.86M | Buy |
+94,450
| New | +$5.86M | 2.5% | 22 |
|